KLK3 and prostate cancer: Therefore, because of the low application threshold, PSA monitoring is indispensable at the moment, and should be integrated into routine health examinations of men aged ≥45 years, as recommended in the latest 2018 German S3-guidelines for Prostate Cancer [116].